Navigation Links
Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
Date:5/29/2012

NEW YORK, May 29, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company") (Nasdaq: CHTP).   

(Logo:  http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that:  (1) Chelsea's Northera (droxidopa) product, an orally-active synthetic precursor of norepinephrine being developed for the treatment of symptomatic neurogenic orthostatic hypotension, would not receive approval from the U.S. Food and Drug Administration; and (2) the Company's numerous statements regarding the safety and efficacy of the product, as well as reportedly positive results from Northera's clinical trials, were materially false and misleading.

On February 13, 2012, Chelsea disclosed that the Food and Drug Administration ("FDA") had raised questions regarding the efficacy, size and duration of the Company's clinical trials for the drug Northera.  Furthermore, the FDA indicated that three deaths were potentially related to the drug's trials.  In the aftermath of these disclosures, Chelsea's stock price declined by more than 37 %. Then on March 28, 2012, the Company announced that its New Drug Application for Northera was rejected by the FDA. Upon this news, Chelsea shares fell more than 28%, to close at $2.62 per share on March 29, 2012.

Request more information now by clicking here:  www.faruqilaw.com/CHTP

Take Action

If you purchased Chelsea securities between November 3, 2008 and March 28, 2012 and would like to discuss your legal rights, visit www.faruqilaw.com/CHTP.  You can also
'/>"/>

SOURCE Faruqi & Faruqi, LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Faruqi & Faruqi, LLP Announces Investigation of ZELTIQ Aesthetics, Inc.
4. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
5. Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.
6. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
7. Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV)
8. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
9. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
10. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
11. Medical Device Developers - Network at MD&M East Next Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... months endedChange %  30 September 201430 September 2013Turnover 546,011 , ... , 384,242 , 339,113 , 13.3 ... , 49.5 Medical Insurance Administration Service Income , ... Devices and Accessories Sales , 94,580 , 142,683 ... 2,917 , 9,219 , (68.4) Impairment Loss on ...
(Date:11/26/2014)... Nov. 26, 2014   Royal Philips ... announced expanded availability of its portfolio of ... wDR, MobileDiagnost Opta[i] , ProGrade and PrimaryDiagnost[ii]. With ... available in the U.S., and availability of all ... offers Philips, customers innovative solutions designed to meet ...
(Date:11/26/2014)... , Nov. 26, 2014 Lexicon Pharmaceuticals, ... the completion of previously announced concurrent financing transactions ... fees and estimated offering expenses, Lexicon anticipates net ...  The transactions consisted of: , a ... pursuant to a registration statement that has been ...
Breaking Medicine Technology:Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... at High,Risk , ,WASHINGTON, March 9, 2007 ... history of end-stage renal disease (ESRD), and,these individuals appear ... reports a study in the April Journal of,the American ... disease is more frequent in,African-Americans, who are also at ...
... Pharmaceuticals,Inc. (OTCBB:CGXP), a biopharmaceutical company focused on,infectious ... catheter,treated with a Ceragenin compound demonstrated virtually ... In the study, polyurethane catheters treated with ... along with an,untreated catheter. At day 21, ...
Cached Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
(Date:11/28/2014)... The Alternative Health Therapies ... five years. The industry has been buoyed by ... either alternative to conventional Western medicine or complementary ... David Whytcross, “industry revenue has been further boosted ... insurance membership.” Meanwhile, improving economic conditions following the ...
(Date:11/28/2014)... 27, 2014 (HealthDay News) -- Planning on seconds at ... heartburn -- clinically known as gastroesophageal reflux disease (GERD) -- ... Jordan Josephson, an ear, nose and throat specialist at Lenox ... to help manage GERD on Thanksgiving: Pace ... least two small meals throughout the day. It,s also a ...
(Date:11/28/2014)... November 28, 2014 An inventor and dental ... on a patient’s filling and it was almost impossible to ... curing light," she said. , The patent-pending Access Light allows ... access to areas of the mouth, as well as avoids ... and safety. Easy to use and clean, it also helps ...
(Date:11/28/2014)... November 28, 2014 A newly released ... an overview of the influenza virus that will soon be ... , The article begins with a brief explanation of ... symptoms. It reminds families that children under the age of ... from chronic diseases, such as heart and lung diseases, asthma, ...
(Date:11/28/2014)... November 28, 2014 "Most of my life, ... to use crutches," said an inventor from Findlay, Ohio. "I ... way to support my foot, which inspired me to invent ... offer a convenient way to support an injured foot. The ... It eliminates the need for crutches. The design redistributes weight ...
Breaking Medicine News(10 mins):Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... gastrointestinal bleeding accounts for approximately 20% of emergency ... has been used as a first-line treatment option ... be used as a safe diagnostic and treatment ... refractory to endoscopic treatment. The incidence of rebleeding ...
... , , , VIENNA, ... Industries Ltd. (Nasdaq: TEVA ), today announced results ... corticosteroids (ICSs) in a "real-life" asthmatic population. The study ... to effectively treat both large and small airway inflammation, to ...
... , WASHINGTON, Sept. 16 Antidepressant drug ... year, has been known to cause birth defects, but the ... a Philadelphia court has heard. , , ... the drug and urged scientists to conceal Paxil,s risks. The ...
... , , BRAINTREE, Mass. and ... HAE ) announced today that it has signed a ... a cooperative of community blood centers. The contract provides ... of innovative blood management software products, including Prelude and Interlude, ...
... finds supervised exercise has better results , WEDNESDAY, Sept. ... shockwave treatment for relieving chronic shoulder pain, according to ... to treat shoulder pain, even though a number of ... Norwegian researchers studied 104 men and women, aged 18 ...
... , , WASHINGTON, Sept. ... Orthotic and Prosthetic Association today announced that Senators Tom Harkin ... Miller, and Lincoln Diaz-Balart are recipients of their joint organizations, ... view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/aopa/40117/ ...
Cached Medicine News:Health News:Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options 2Health News:Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options 3Health News:Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options 4Health News:Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage 2Health News:Haemonetics Signs Comprehensive Agreement with Blood Centers of America 2Health News:Shockwave Treatment May Not Be Best for Shoulder Pain 2Health News:Video: Members of Congress Receive Legislative Awards From National Amputee Organizations 2Health News:Video: Members of Congress Receive Legislative Awards From National Amputee Organizations 3
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... Ophthalmics offers the most comprehensive family ... Instruments for Cataract incision, Glaucoma filtration, ... coagulation is achieved with minimal tissue ... Straight eraser styles are available in ...
Medicine Products: